Published in J Acquir Immune Defic Syndr on November 01, 2009
Improving public health information: a data quality intervention in KwaZulu-Natal, South Africa. Bull World Health Organ (2011) 2.37
An assessment of routine primary care health information system data quality in Sofala Province, Mozambique. Popul Health Metr (2011) 2.14
Scale-up of HIV treatment through PEPFAR: a historic public health achievement. J Acquir Immune Defic Syndr (2012) 1.78
The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon? J Health Care Poor Underserved (2013) 1.75
Assessing the ability of health information systems in hospitals to support evidence-informed decisions in Kenya. Glob Health Action (2014) 1.28
Approaches to ensuring and improving quality in the context of health system strengthening: a cross-site analysis of the five African Health Initiative Partnership programs. BMC Health Serv Res (2013) 1.19
Aligning vertical interventions to health systems: a case study of the HIV monitoring and evaluation system in South Africa. Health Res Policy Syst (2012) 1.17
An assessment of the accuracy and availability of data in electronic patient tracking systems for patients receiving HIV treatment in central Mozambique. BMC Health Serv Res (2012) 1.12
Improving the quality of health information: a qualitative assessment of data management and reporting systems in Botswana. Health Res Policy Syst (2014) 1.12
Implementation of a health management mentoring program: year-1 evaluation of its impact on health system strengthening in Zambézia Province, Mozambique. Int J Health Policy Manag (2015) 1.08
Establishing a health information workforce: innovation for low- and middle-income countries. Hum Resour Health (2013) 0.99
Introduction and evaluation of a 'pre-ART care' service in Swaziland: an operational research study. BMJ Open (2012) 0.99
A three-tier framework for monitoring antiretroviral therapy in high HIV burden settings. J Int AIDS Soc (2014) 0.99
The HIV/AIDS epidemic in sub-Saharan Africa: thinking ahead on programmatic tasks and related operational research. J Int AIDS Soc (2011) 0.88
Strengthening monitoring and evaluation (M&E) and building sustainable health information systems in resource limited countries: lessons learned from an M&E task-shifting initiative in Botswana. BMC Public Health (2014) 0.86
Strategies for monitoring and evaluation of resource-limited national antiretroviral therapy programs: the two-phase design. BMC Med Res Methodol (2015) 0.78
Monitoring quality at scale: implementing quality assurance in a diverse, multicountry HIV program. AIDS (2015) 0.75
Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014. J Int AIDS Soc (2017) 0.75
Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries. Clin Infect Dis (2013) 2.91
Relation between cord blood mercury levels and early child development in a World Trade Center cohort. Environ Health Perspect (2008) 2.13
Adult clinical and immunologic outcomes of the national antiretroviral treatment program in Rwanda during 2004-2005. J Acquir Immune Defic Syndr (2009) 2.07
HIV-associated orphanhood and children's psychosocial distress: theoretical framework tested with data from Zimbabwe. Am J Public Health (2007) 2.03
Focus on women: linking HIV care and treatment with reproductive health services in the MTCT-Plus Initiative. Reprod Health Matters (2005) 1.77
The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon? J Health Care Poor Underserved (2013) 1.75
The effects of the World Trade Center event on birth outcomes among term deliveries at three lower Manhattan hospitals. Environ Health Perspect (2004) 1.74
Quality improvement implementation and hospital performance on quality indicators. Health Serv Res (2006) 1.55
High attrition before and after ART initiation among youth (15-24 years of age) enrolled in HIV care. AIDS (2014) 1.48
Factors associated with late antiretroviral therapy initiation among adults in Mozambique. PLoS One (2012) 1.46
Patients enrolled in HIV care in Mozambique: baseline characteristics and follow-up outcomes. J Acquir Immune Defic Syndr (2011) 1.32
High levels of adherence and viral suppression in a nationally representative sample of HIV-infected adults on antiretroviral therapy for 6, 12 and 18 months in Rwanda. PLoS One (2013) 1.32
The human adenocarcinoma-associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-activator YAP1 activation. J Biol Chem (2011) 1.31
Quality improvement implementation and hospital performance on patient safety indicators. Med Care Res Rev (2006) 1.27
Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009. J Int AIDS Soc (2011) 1.24
TB diagnostic capacity in sub-Saharan African HIV care settings. J Acquir Immune Defic Syndr (2012) 1.22
Decentralization of pediatric HIV care and treatment in five sub-Saharan African countries. J Acquir Immune Defic Syndr (2013) 1.20
Determinants of nonadherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Rwanda. J Acquir Immune Defic Syndr (2009) 1.17
Advanced disease at enrollment in HIV care in four sub-Saharan African countries: change from 2006 to 2011 and multilevel predictors in 2011. AIDS (2014) 1.17
Poorer health and nutritional outcomes in orphans and vulnerable young children not explained by greater exposure to extreme poverty in Zimbabwe. Trop Med Int Health (2007) 1.16
PEPFAR programs linked to more deliveries in health facilities by African women who are not infected with HIV. Health Aff (Millwood) (2012) 1.10
Mifepristone-misoprostol abortion: a trial in rural and urban Maharashtra, India. Contraception (2002) 1.10
Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults--seven African countries, 2004-2013. MMWR Morb Mortal Wkly Rep (2014) 1.10
Disclosure, knowledge of partner status, and condom use among HIV-positive patients attending clinical care in Tanzania, Kenya, and Namibia. AIDS Patient Care STDS (2013) 1.07
Relationship between polycyclic aromatic hydrocarbon-DNA adducts, environmental tobacco smoke, and child development in the World Trade Center cohort. Environ Health Perspect (2007) 1.05
Factors associated with loss to clinic among HIV patients not yet known to be eligible for antiretroviral therapy (ART) in Mozambique. J Int AIDS Soc (2013) 1.03
Beyond indicators: advances in global HIV monitoring and evaluation during the PEPFAR era. J Acquir Immune Defic Syndr (2012) 1.02
Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center. Contraception (2007) 1.00
The steady-state pharmacokinetics of nelfinavir in combination with tenofovir in HIV-infected patients. Antivir Ther (2005) 0.95
Availability of nutritional support services in HIV care and treatment sites in sub-Saharan African countries. Public Health Nutr (2011) 0.94
HIV prevention in care and treatment settings: baseline risk behaviors among HIV patients in Kenya, Namibia, and Tanzania. PLoS One (2013) 0.90
The effect of the CYP2C19*2 heterozygote genotype on the pharmacokinetics of nelfinavir. Br J Clin Pharmacol (2006) 0.88
Use of a Comprehensive HIV Care Cascade for Evaluating HIV Program Performance: Findings From 4 Sub-Saharan African Countries. J Acquir Immune Defic Syndr (2015) 0.87
Lower Levels of Antiretroviral Therapy Enrollment Among Men with HIV Compared with Women - 12 Countries, 2002-2013. MMWR Morb Mortal Wkly Rep (2015) 0.86
Loss of anterior gradient 2 (Agr2) expression results in hyperplasia and defective lineage maturation in the murine stomach. J Biol Chem (2012) 0.85
Decentralization of HIV care and treatment services in Central Province, Kenya. J Acquir Immune Defic Syndr (2014) 0.84
Effects of nelfinavir and its M8 metabolite on lymphocyte P-glycoprotein activity during antiretroviral therapy. Clin Pharmacol Ther (2003) 0.83
Training multidisciplinary teams to deliver high-quality HIV care to families in resource-limited settings: the MTCT-Plus initiative experience. J Assoc Nurses AIDS Care (2012) 0.83
Putting quality at the heart of HIV programs. AIDS (2015) 0.83
Encapsulated papillary carcinoma of the breast: a study of invasion associated markers. J Clin Pathol (2012) 0.81
Untangling the Relationship Between Antiretroviral Therapy Use and Incident Pregnancy: A Marginal Structural Model Analysis Using Data From 47,313 HIV-Positive Women in East Africa. J Acquir Immune Defic Syndr (2016) 0.80
Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012. J Acquir Immune Defic Syndr (2016) 0.79
Association between HIV programs and quality of maternal health inputs and processes in Kenya. Am J Public Health (2015) 0.79
Low risk of attrition among adults on antiretroviral therapy in the Rwandan national program: a retrospective cohort analysis of 6, 12, and 18 month outcomes. BMC Public Health (2014) 0.78
Implementation and Operational Research: Evaluation of Swaziland's Hub-and-Spoke Model for Decentralizing Access to Antiretroviral Therapy Services. J Acquir Immune Defic Syndr (2015) 0.78
Decentralizing Access to Antiretroviral Therapy for Children Living with HIV in Swaziland. Pediatr Infect Dis J (2016) 0.78
Feasibility and Acceptability of Health Communication Interventions Within a Combination Intervention Strategy for Improving Linkage and Retention in HIV Care in Mozambique. J Acquir Immune Defic Syndr (2017) 0.77
Bridging the divide. J Acquir Immune Defic Syndr (2011) 0.77
Population health and individualized care in the global AIDS response: synergy or conflict? AIDS (2016) 0.77
Saquinavir, nelfinavir and M8 pharmacokinetics following combined saquinavir, ritonavir and nelfinavir administration. J Antimicrob Chemother (2007) 0.77
Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient-Provider Communication in the START Study. J Acquir Immune Defic Syndr (2017) 0.77
Modeling exposure to air pollution from the WTC disaster based on reports of perceived air pollution. Risk Anal (2008) 0.76
Monitoring quality at scale: implementing quality assurance in a diverse, multicountry HIV program. AIDS (2015) 0.75
Trends in Prevalence of Advanced HIV Disease at Antiretroviral Therapy Enrollment - 10 Countries, 2004-2015. MMWR Morb Mortal Wkly Rep (2017) 0.75
Sex Differences in Mortality and Loss Among 21,461 Older Adults on Antiretroviral Therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr (2016) 0.75
Imperfect tools. Minn Med (2004) 0.75
Ebola: the real lessons from HIV scale-up. Lancet Infect Dis (2015) 0.75
Stigma And HIV Care Continuum Outcomes Among Ethiopian Adults Initiating ART. J Acquir Immune Defic Syndr (2017) 0.75
Reply. J Acquir Immune Defic Syndr (2017) 0.75
Feasibility and Acceptability of Health Communication Interventions Within a Combination Intervention Strategy for Improving Linkage and Retention in HIV Care in Mozambique. J Acquir Immune Defic Syndr (2017) 0.75
Rejoinder to "Lost Opportunities Concerning Loss-to-Follow-Up: A Response to Elul et al." by Strassle and colleagues. J Acquir Immune Defic Syndr (2017) 0.75
Pharmacokinetics of nelfinavir in subjects with hepatic impairment. J Clin Pharmacol (2006) 0.75
Previewing Distractors Improves Change Detection in a Change Blindness Paradigm. J Vis (2015) 0.75
Memory is Necessary in Visual Search with Limited Guidance. J Vis (2015) 0.75
Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient-Provider Communication in the START Study. J Acquir Immune Defic Syndr (2017) 0.75